Your search for evid returned 22 results

Pharmacotherapeutic issues associated with generic substitutions of antiseizure medications may not only be the result of the FDA’s bioequivalence standards.

The study aimed to identify medication classes and specific SSRIs that provide high rates of remission as well as a low risk of adverse events when used in the treatment of panic disorder with or without agoraphobia.

The retrospective review included 6 pediatric patients younger than 12 months of age in the neonatal intensive care unit.

While no drugs are currently approved for the treatment of BPD, nearly all patients with this condition receive at least 1 psychotropic medication.

Although NASH is a common cause of chronic liver disease, there is limited evidence surrounding its management.

Increased incidence of CAP was noted in stroke patients using PPIs.

The study authors obtained randomized clinical trials comparing oseltamivir, peramivir, zanamivir, and baloxavir with other active agents or placebo.

The analysis included 5 antiseizure medications (eslicarbazepine, perampanel, brivaracetam, cannabidiol, and cenobamate) evaluated in 17 randomized clinical trials.

Each additional cup of habitual coffee consumed reduced the risk of incident arrhythmia by 3%.

Despite an increasing emphasis on HFmrEF over the past several years, there is a lack of authoritative guidance surrounding therapeutic approaches for these patients.